SYLVANT siltuximab (rmc) 100mg powder for injection vial

Approval Id: d5a41e4df72200e6
Product Name: SYLVANT siltuximab (rmc) 100mg powder for injection vial
Artg Id: 229996
Artg Name: SYLVANT siltuximab (rmc) 100mg powder for injection vial
Sponsor: Recordati Rare Diseases Australia Pty Ltd
Company Detail Path: /organization/recordati-rare-diseases-australia-pty-ltd
Artg Date: 2015-08-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-02500-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02499-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d5a41e4df72200e6

Type

Standard